PPARβ siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Free Cholesterol‐Induced Liver Injury in Non‐Alcoholic Fatty Liver Disease: Mechanisms and a Therapeutic Intervention Using Dihydrotanshinone IAdvanced ScienceNovember 19, 2024Jia‐Wen Shou, Juncai Ma, Xuchu Wang, Xiao‐Xiao Li, Shu‐Cheng Chen, Byung‐Ho Kang, Pang‐Chui Shawsc‐36308; Santa Cruz), Pparγ siRNA (human: sc‐29455; mouse: sc‐29456; Santa Cruz) or Pparδ siRNA (human: sc‐36305; mouse: sc‐36306) was carried out using Lipofectamine 2000 (11668027, Thermo Fisher Scientific) as recommended

(2) GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer CellsCellsApril 19, 2024Barbaud A, Lascombe I, Péchery A, Arslan S, Kleinclauss F, Fauconnet S.Cell Transfection Control siRNA (negative control for evaluating RNAi off-target effects, sc-37007), PPARβ/δ (sc-36305), Adam10 (sc-41410), and Tspan15 (sc-90664) specific siRNA (pool of 3 target-specific 19–25 nucleotide

(3) Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cellsArchives of biochemistry and biophysicsNovember 30, 2022Hirao-Suzuki M, Takayuki K, Takiguchi M, Peters JM, Takeda S.

(4) HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma modelsThe Journal of clinical investigationJuly 1, 2020Nguyen TTT, Zhang Y, Shang E, Shu C, Torrini C, Zhao J, Bianchetti E, Mela A, Humala N, Mahajan A, et al.

(6) Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ)European journal of medicinal chemistryDecember 1, 2017Szychowski KA, Leja ML, Kaminskyy DV, Kryshchyshyn AP, Binduga UE, Pinyazhko OR, Lesyk RB, Tobiasz J, Gmiński J.

(9) Suppression of PPARβ, and DHA treatment, inhibit NaV1.5 and NHE-1 pro-invasive activitiesPflugers Archiv : European journal of physiologyJune 1, 2015Wannous R, Bon E, Gillet L, Chamouton J, Weber G, Brisson L, Goré J, Bougnoux P, Besson P, Roger S, et al.

(10) Preclinical studies of a specific PPARγ modulator in the control of skin inflammationThe Journal of investigative dermatologyApril 1, 2014Mastrofrancesco A, Kovacs D, Sarra M, Bastonini E, Cardinali G, Aspite N, Camera E, Chavatte P, Desreumaux P, Monteleone G, et al.

(12) An Ethanol Extract of Artemisia iwayomogi Activates PPARδ Leading to Activation of Fatty Acid Oxidation in Skeletal MusclePLoS ONEMarch 27, 2012Si Young Cho, Hyun Woo Jeong, Jong Hee Sohn, Dae-Bang Seo, Wan Gi Kim, Sang-Jun LeeTreatment The PPARδ small interfering RNA (siRNA) pool (a mixture of three siRNAs for PPARδ, cat. no. sc-36305) and control siRNA (cat. no. sc-37007) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,

(13) PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1Pflugers Archiv : European journal of physiologyApril 1, 2010Michiels JF, Perrin C, Leccia N, Massi D, Grimaldi P, Wagner N.

(14) Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alphaCancer researchAugust 15, 2009Sun X, Ritzenthaler JD, Zhong X, Zheng Y, Roman J, Han S.sample buffer and analyzed by Western blot. Short interfering RNA (siRNA) treatment The PPARβ/δ siRNA (sc-36305), α7 nAChR siRNA (sc-42532), AP-2α siRNA (sc-29200), Sp1 siRNA (sc-29487), control siRNA (sc-37007)

(15) Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alphaAmerican journal of respiratory cell and molecular biologyMarch 1, 2009Han S, Ritzenthaler JD, Sun X, Zheng Y, Roman J.control rabbit IgG. Small Interfering RNA Treatment The PPARb/d small interfering RNA (siRNA) (cat. no. sc-36305), PGC-1a siRNA (h) (cat. no. sc-38884), AMPKa siRNA (cat. no. sc45321), and control siRNA (cat. no.

PPARβ siRNA (h)